GP
About
Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, their respected family-owned Swiss parent company has pioneered technological advances that make regenerative treatment, with safe and naturally sourced biomaterials, the preferred choice for clinical predictability.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 125 investors are based in Princeton, New Jersey, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Princeton, US
Contact Information
Find more investors like Geistlich
Search Investors